,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription Writi
wd wd wd wd wd wd wd wd wd wd
ng
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
wd wd wd wd wd wd wd wd
MULTIPLE CHOICE wd
1. Knowledge of pharmacology aids the dental professional in wd wd wd wd wd wd wd
a. obtaining a patient’s health history. wd wd wd wd
b. administering drugs in the office. wd wd wd wd
c. handling emergency situations. wd wd
d. selection of a nonprescription medication. wd wd wd wd
e. All of the above. wd wd wd
ANS: E w d
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of ph
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
armacology helps in understanding and interpreting patients’ responses to health history questions. Kno
wd wd wd wd wd wd wd wd wd wd wd wd
wledge of the therapeutic and adverse effects of medications obviously helps in their proper administrat
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ion in the office. Emergency situations may be caused by drugs or treated by drugs; thus, knowledge of
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
pharmacology is of great help, especially because a rapid response is sometimes required. A clear under
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
standing of the concepts of drug action, drug handling by the body, and drug interactions will allow the
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
dental practitioner to make proper judgments and grasp the concepts relevant to new drug therapies on t
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
he market.
wd
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
w d wd wd wd wd wd wd wd wd wd wd wd wd wd
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist (Nonpr
wd wd wd wd wd wd wd wd wd wd wd wd wd
escription Medication) | pp. 2-3 OBJ:
wd 1 wd wd wd
TOP: NBDHE, 6.0. Pharmacology
w d wd wd
2. Which of the following statements is true regarding planning appointments?
wd wd wd wd wd wd wd wd wd
a. Whether or not patients are taking medication for systemic diseases is of little
wd wd wd wd wd wd wd wd wd wd wd wd
consequence in the dental office. wd wd wd wd
b. Asthmatic patients should have dental appointments in the morning. wd wd wd wd wd wd wd wd
c. Diabetic patients usually have fewer problems with a morning appointment comwd wd wd wd wd wd wd wd wd wd
pared with afternoon appointments. wd wd wd
d. Both B and C are true. wd wd wd wd wd
ANS: D w d
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
wd wd wd wd wd wd wd wd wd wd wd wd wd
rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
with a morning appointment. Patients taking medication for systemic diseases may require special hand
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ling in the dental office.
wd wd wd wd
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
w d wd wd wd wd wd wd wd wd wd w
OBJ: 1
d TOP: NBDHE, 6.0. Pharmacology
w d w d wd wd
,3. Nutritional or herbal supplements wd wd wd
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
wd wd wd wd wd wd wd wd wd wd wd
b. are not drugs. wd wd
c. can cause adverse effects. wd wd wd
d. will not interact with other drugs the patient may be taking.
wd wd wd wd wd wd wd wd wd wd
ANS: C w d
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
or herbal supplements do not carry FDA approval for treating disease states. These supplements are drug
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
s and can cause adverse effects and interact with different drugs.
wd wd wd wd wd wd wd wd wd wd
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3
w d wd wd wd wd wd wd wd wd wd wd wd wd
OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
w d w d wd wd
4. Which type of drug name usually begins with a lowercase letter?
wd wd wd wd wd wd wd wd wd wd
a. Brand name wd
b. Code name wd
c. Generic name wd
d. Trade name wd
ANS: C w d
Before any drug is marketed, it is given a generic name that becomes the “official” name of the drug. Ea
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ch drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
not capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
name is technically the name of the company marketing the product, this term is often used interchangea
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
bly with the trade name. The code name is the initial term used within a pharmaceutical company to ref
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
er to a drug while it is undergoing investigation and is often a combination of capital letters and number
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
s, the letters representing an abbreviation of the company name.
wd wd wd wd wd wd wd wd wd
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3 w d wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
5. A drug’s generic name is selected by the
wd wd wd wd wd wd wd
a. pharmaceutical company manufacturing it. wd wd wd
b. Food and Drug Administration (FDA). wd wd wd wd
c. U.S. Adopted Name Council. wd wd wd
d. Federal Patent Office. wd wd
ANS: C w d
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
company manufacturing the drug clearly has an influence on the generic name given its drug, but the fin
d wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
al decision is not the company’s.
wd wd wd wd wd
DIF: Recall REF: Drug Names | p. 4 w d wd wd wd wd
OBJ: 3 TOP: NBDHE, 6.0. Pharmacology w d wd w d wd wd
6. Which of the following is true concerning generic and trade names of drugs?
wd wd wd wd wd wd wd wd wd wd wd wd
a. A drug may only have one generic name and one trade name.
wd wd wd wd wd wd wd wd wd wd wd
, b. A drug may only have one generic name, but it may have several trade names.
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
c. A drug may have several generic names, but it may only have one trade name.
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
d. A drug may have several generic names and several trade names.
wd wd wd wd wd wd wd wd wd wd
ANS: B w d
Each drug has only one generic name but may have several trade names. For each drug, there is only on
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
e generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
company discovering the drug gives the drug a trade name. The trade name is protected by the Federal P
d wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
atent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the br
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
and name is technically the name of the company marketing the product, it is often used interchangeably
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
with the trade name.
d wd wd wd
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3 w d wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent or th
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
erapeutically equivalent are said to differ in wd wd wd wd wd wd
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. wd
ANS: C w d
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These pr
wd wd wd wd wd wd wd wd wd wd wd wd wd
oducts are said to differ in their bioavailability. The potency of a drug is a function of the amount of drug
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
required to produce an effect. The efficacy is the maximum intensity of effect or response that can be pr
d wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
oduced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental anim
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
als divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic ind
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ex is small, toxicity is more likely.
wd wd wd wd wd wd
DIF: Recall
REF: Drug Names (Drug Substitution) | p. 5 OBJ: 4
w d wd wd wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
8. How many years must pass after a drug patent expires before other drug companies can market the sa
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
me compound as a generic drug?
wd wd wd wd wd
a. 20 years wd
b. 17 years wd
c. 7 years wd
d. 0 years wd
ANS: D w d
Once a drug patent expires, competing companies may immediately market the same compound in gen
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
eric form. The pharmaceutical company discovering the drug gives the drug a trade name. The trade na
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
me is protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the pate
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
nt term extensions.
wd wd
DIF: Application
REF: Drug Names (Drug Substitution) | p. 5 OBJ: 4
w d wd wd wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
wd wd wd wd wd wd wd wd wd wd
ng
Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
wd wd wd wd wd wd wd wd
MULTIPLE CHOICE wd
1. Knowledge of pharmacology aids the dental professional in wd wd wd wd wd wd wd
a. obtaining a patient’s health history. wd wd wd wd
b. administering drugs in the office. wd wd wd wd
c. handling emergency situations. wd wd
d. selection of a nonprescription medication. wd wd wd wd
e. All of the above. wd wd wd
ANS: E w d
All of the choices are true. Because many of our patients are being treated with drugs, knowledge of ph
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
armacology helps in understanding and interpreting patients’ responses to health history questions. Kno
wd wd wd wd wd wd wd wd wd wd wd wd
wledge of the therapeutic and adverse effects of medications obviously helps in their proper administrat
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ion in the office. Emergency situations may be caused by drugs or treated by drugs; thus, knowledge of
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
pharmacology is of great help, especially because a rapid response is sometimes required. A clear under
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
standing of the concepts of drug action, drug handling by the body, and drug interactions will allow the
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
dental practitioner to make proper judgments and grasp the concepts relevant to new drug therapies on t
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
he market.
wd
DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (Medication
w d wd wd wd wd wd wd wd wd wd wd wd wd wd
Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental Hygienist (Nonpr
wd wd wd wd wd wd wd wd wd wd wd wd wd
escription Medication) | pp. 2-3 OBJ:
wd 1 wd wd wd
TOP: NBDHE, 6.0. Pharmacology
w d wd wd
2. Which of the following statements is true regarding planning appointments?
wd wd wd wd wd wd wd wd wd
a. Whether or not patients are taking medication for systemic diseases is of little
wd wd wd wd wd wd wd wd wd wd wd wd
consequence in the dental office. wd wd wd wd
b. Asthmatic patients should have dental appointments in the morning. wd wd wd wd wd wd wd wd
c. Diabetic patients usually have fewer problems with a morning appointment comwd wd wd wd wd wd wd wd wd wd
pared with afternoon appointments. wd wd wd
d. Both B and C are true. wd wd wd wd wd
ANS: D w d
Asthmatic patients who experience dental anxiety should schedule their appointments when they are not
wd wd wd wd wd wd wd wd wd wd wd wd wd
rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer problems
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
with a morning appointment. Patients taking medication for systemic diseases may require special hand
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ling in the dental office.
wd wd wd wd
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | p. 3
w d wd wd wd wd wd wd wd wd wd w
OBJ: 1
d TOP: NBDHE, 6.0. Pharmacology
w d w d wd wd
,3. Nutritional or herbal supplements wd wd wd
a. carry the U.S. Food and Drug Administration (FDA) approval for disease states.
wd wd wd wd wd wd wd wd wd wd wd
b. are not drugs. wd wd
c. can cause adverse effects. wd wd wd
d. will not interact with other drugs the patient may be taking.
wd wd wd wd wd wd wd wd wd wd
ANS: C w d
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of nutritional
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
or herbal supplements do not carry FDA approval for treating disease states. These supplements are drug
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
s and can cause adverse effects and interact with different drugs.
wd wd wd wd wd wd wd wd wd wd
DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements) | p. 3
w d wd wd wd wd wd wd wd wd wd wd wd wd
OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
w d w d wd wd
4. Which type of drug name usually begins with a lowercase letter?
wd wd wd wd wd wd wd wd wd wd
a. Brand name wd
b. Code name wd
c. Generic name wd
d. Trade name wd
ANS: C w d
Before any drug is marketed, it is given a generic name that becomes the “official” name of the drug. Ea
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ch drug is assigned only one generic name selected by the U.S. Adopted Name Council, and the name is
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
not capitalized. The brand name is equivalent to the trade name and is capitalized. Although the brand
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
name is technically the name of the company marketing the product, this term is often used interchangea
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
bly with the trade name. The code name is the initial term used within a pharmaceutical company to ref
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
er to a drug while it is undergoing investigation and is often a combination of capital letters and number
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
s, the letters representing an abbreviation of the company name.
wd wd wd wd wd wd wd wd wd
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3 w d wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
5. A drug’s generic name is selected by the
wd wd wd wd wd wd wd
a. pharmaceutical company manufacturing it. wd wd wd
b. Food and Drug Administration (FDA). wd wd wd wd
c. U.S. Adopted Name Council. wd wd wd
d. Federal Patent Office. wd wd
ANS: C w d
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted Name
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
Council. The generic name is not selected by the FDA or the Federal Patent Office. The pharmaceutical
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
company manufacturing the drug clearly has an influence on the generic name given its drug, but the fin
d wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
al decision is not the company’s.
wd wd wd wd wd
DIF: Recall REF: Drug Names | p. 4 w d wd wd wd wd
OBJ: 3 TOP: NBDHE, 6.0. Pharmacology w d wd w d wd wd
6. Which of the following is true concerning generic and trade names of drugs?
wd wd wd wd wd wd wd wd wd wd wd wd
a. A drug may only have one generic name and one trade name.
wd wd wd wd wd wd wd wd wd wd wd
, b. A drug may only have one generic name, but it may have several trade names.
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
c. A drug may have several generic names, but it may only have one trade name.
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
d. A drug may have several generic names and several trade names.
wd wd wd wd wd wd wd wd wd wd
ANS: B w d
Each drug has only one generic name but may have several trade names. For each drug, there is only on
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
e generic name. It is not capitalized, and it becomes the “official” name of the drug. The pharmaceutical
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
company discovering the drug gives the drug a trade name. The trade name is protected by the Federal P
d wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
atent Law for 20 years from the earliest claimed filing date, plus patent term extensions. Although the br
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
and name is technically the name of the company marketing the product, it is often used interchangeably
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
with the trade name.
d wd wd wd
DIF: Comprehension
REF: Drug Names | p. 4 OBJ: 3 w d wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
7. Two drugs that are found to be chemically equivalent, but not biologically equivalent or th
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
erapeutically equivalent are said to differ in wd wd wd wd wd wd
a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. wd
ANS: C w d
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent. These pr
wd wd wd wd wd wd wd wd wd wd wd wd wd
oducts are said to differ in their bioavailability. The potency of a drug is a function of the amount of drug
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd w
required to produce an effect. The efficacy is the maximum intensity of effect or response that can be pr
d wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
oduced by a drug. The therapeutic index is the ratio of the lethal dose for 50% of the experimental anim
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
als divided by the effective dose for 50% of the experimental animals. If the value of the therapeutic ind
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
ex is small, toxicity is more likely.
wd wd wd wd wd wd
DIF: Recall
REF: Drug Names (Drug Substitution) | p. 5 OBJ: 4
w d wd wd wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
8. How many years must pass after a drug patent expires before other drug companies can market the sa
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
me compound as a generic drug?
wd wd wd wd wd
a. 20 years wd
b. 17 years wd
c. 7 years wd
d. 0 years wd
ANS: D w d
Once a drug patent expires, competing companies may immediately market the same compound in gen
wd wd wd wd wd wd wd wd wd wd wd wd wd wd
eric form. The pharmaceutical company discovering the drug gives the drug a trade name. The trade na
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
me is protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus the pate
wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd wd
nt term extensions.
wd wd
DIF: Application
REF: Drug Names (Drug Substitution) | p. 5 OBJ: 4
w d wd wd wd wd wd wd wd w d
TOP: NBDHE, 6.0. Pharmacology w d wd wd
